1. Home
  2. PEN vs COKE Comparison

PEN vs COKE Comparison

Compare PEN & COKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PEN
  • COKE
  • Stock Information
  • Founded
  • PEN 2004
  • COKE 1902
  • Country
  • PEN United States
  • COKE United States
  • Employees
  • PEN N/A
  • COKE N/A
  • Industry
  • PEN Medical/Dental Instruments
  • COKE Beverages (Production/Distribution)
  • Sector
  • PEN Health Care
  • COKE Consumer Staples
  • Exchange
  • PEN Nasdaq
  • COKE Nasdaq
  • Market Cap
  • PEN 11.1B
  • COKE 11.7B
  • IPO Year
  • PEN 2015
  • COKE N/A
  • Fundamental
  • Price
  • PEN $267.51
  • COKE $1,330.20
  • Analyst Decision
  • PEN Strong Buy
  • COKE
  • Analyst Count
  • PEN 16
  • COKE 0
  • Target Price
  • PEN $291.60
  • COKE N/A
  • AVG Volume (30 Days)
  • PEN 413.7K
  • COKE 53.5K
  • Earning Date
  • PEN 05-06-2025
  • COKE 05-05-2025
  • Dividend Yield
  • PEN N/A
  • COKE 0.75%
  • EPS Growth
  • PEN N/A
  • COKE 60.86
  • EPS
  • PEN 0.36
  • COKE 69.94
  • Revenue
  • PEN $1,194,615,000.00
  • COKE $6,899,716,000.00
  • Revenue This Year
  • PEN $14.26
  • COKE N/A
  • Revenue Next Year
  • PEN $14.29
  • COKE N/A
  • P/E Ratio
  • PEN $733.61
  • COKE $18.80
  • Revenue Growth
  • PEN 12.86
  • COKE 3.69
  • 52 Week Low
  • PEN $148.00
  • COKE $800.76
  • 52 Week High
  • PEN $310.00
  • COKE $1,460.92
  • Technical
  • Relative Strength Index (RSI)
  • PEN 44.19
  • COKE 50.34
  • Support Level
  • PEN $273.00
  • COKE $1,268.23
  • Resistance Level
  • PEN $288.57
  • COKE $1,334.48
  • Average True Range (ATR)
  • PEN 8.21
  • COKE 35.61
  • MACD
  • PEN -0.93
  • COKE 1.39
  • Stochastic Oscillator
  • PEN 38.19
  • COKE 84.52

About PEN Penumbra Inc.

Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are sold to hospitals and are developed for use by specialist physicians. Within the neurovascular business, the firm offers products for neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. It operates as one reportable segment and its business activity consists of the design, development, manufacturing and marketing of inventive medical products.

About COKE Coca-Cola Consolidated Inc.

Coca-Cola Consolidated Inc distributes, markets and manufactures nonalcoholic beverages. It offer a range of nonalcoholic beverage products and flavors, including both sparkling and still beverages. Sparkling beverages are carbonated beverages and the Company's principal sparkling beverage is Coca Cola. Still beverages include energy products and noncarbonated beverages such as bottled water, ready-to-drink tea, ready-to-drink coffee, enhanced water, juices and sports drinks. The Company has three operating segments: Nonalcoholic Beverages, All Other and Eliminations. key revenue is generated from Nonalcoholic Beverages.

Share on Social Networks: